About Lecia Sequist, MD, MPH

Dr. Sequist is originally from Michigan and studied chemistry at Cornell University. She received her MD from Harvard Medical School and trained in internal medicine at the Brigham and Women’s Hospital and in hematology/oncology at the Dana-Farber Cancer Institute, where she also received an MPH from the Harvard School of Public Health. She joined the faculty at the Massachusetts General Hospital Cancer Center in 2005 and has an active clinical and translational research career, as well as a busy practice caring for patients with lung cancer. She is currently the Landry Family Professor of Medicine at Harvard Medical School and the Director of the Center for Innovation in Early Cancer Detection at Massachusetts General Hospital. She has held grants from the NIH, the DOD, and many private foundations. Dr. Sequist’s research focuses on studying targeted therapeutics for lung cancer and bringing new non-invasive tests like circulating tumor cells and circulating tumor DNA to treat and detect lung cancer. In her free time, she likes to spend time with her husband, two sons and her dog, and is a hockey and dance mom.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Center for Thoracic Cancers, MGH Cancer Center
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Fax: 617-726-0453

Newton: Newton-Wellesley Hospital

MGH Cancer Center at Newton-Wellesley Hospital
2014 Washington St
Newton, MA 02462
Phone: 617-219-1230

Medical Education

  • MD, Harvard Medical School
  • MD, Harvard Medical School/ BWH
  • Residency, Brigham and Women's Hospital
  • Fellowship, Dana Farber Cancer Institute
  • Fellowship, Dana-Farber Cancer Institute
  • Fellowship, Dana-Farber/Partners CancerCare

American Board Certifications

  • Medical Oncology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.